IN2002DE00287A - - Google Patents
Download PDFInfo
- Publication number
- IN2002DE00287A IN2002DE00287A IN287DE2002A IN2002DE00287A IN 2002DE00287 A IN2002DE00287 A IN 2002DE00287A IN 287DE2002 A IN287DE2002 A IN 287DE2002A IN 2002DE00287 A IN2002DE00287 A IN 2002DE00287A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ2757A AUPQ275799A0 (en) | 1999-09-10 | 1999-09-10 | Recombinant bacterium expressing an oligosaccharide receptor mimic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2002DE00287A true IN2002DE00287A (pt) | 2007-03-02 |
Family
ID=3816927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN287DE2002 IN2002DE00287A (pt) | 1999-09-10 | 2002-03-08 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6833130B1 (pt) |
| EP (1) | EP1214396A4 (pt) |
| JP (1) | JP2003514512A (pt) |
| AP (1) | AP2002002444A0 (pt) |
| AU (1) | AUPQ275799A0 (pt) |
| BR (1) | BR0013915A (pt) |
| CA (1) | CA2384081A1 (pt) |
| HU (1) | HUP0202863A3 (pt) |
| IN (1) | IN2002DE00287A (pt) |
| MX (1) | MXPA02002536A (pt) |
| NZ (1) | NZ517821A (pt) |
| OA (1) | OA12020A (pt) |
| PL (1) | PL364796A1 (pt) |
| SK (1) | SK3472002A3 (pt) |
| WO (1) | WO2001019960A1 (pt) |
| ZA (1) | ZA200201958B (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU772356B2 (en) * | 1998-12-04 | 2004-04-22 | Aventis Pasteur Limited | Two-step immunization procedure against chlamydia infection |
| AUPQ275799A0 (en) * | 1999-09-10 | 1999-10-07 | Luminis Pty Limited | Recombinant bacterium expressing an oligosaccharide receptor mimic |
| SE9904581D0 (sv) * | 1999-12-15 | 1999-12-15 | A & Science Invest Ab | A novel helicobacter pylori-binding substance and use thereof |
| US7863020B2 (en) | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
| AU2003256329A1 (en) * | 2002-06-27 | 2004-01-19 | University Of Washington | Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
| EP1524992B1 (en) * | 2002-08-02 | 2015-03-04 | GlaxoSmithKline Biologicals s.a. | Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria menigitidis |
| EP2365089B1 (en) * | 2004-03-17 | 2014-05-14 | GlycoFi, Inc. | Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in yeast |
| WO2005089775A1 (en) * | 2004-03-17 | 2005-09-29 | Adelaide Research And Innovation Pty Ltd | Treatment and prevention of enterotoxigenic escherichia coli diarrhoeas |
| US20070166306A1 (en) * | 2006-01-17 | 2007-07-19 | Fey Georg H M | Anti-CD19 antibody composition and method |
| US8236538B2 (en) * | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
| EP2265135B1 (en) * | 2008-03-14 | 2017-12-20 | Nestec S.A. | Synbiotic mixture |
| EP2116139A1 (en) * | 2008-05-08 | 2009-11-11 | Nestec S.A. | Sialic acid to support brain health in the elderly |
| US20090280104A1 (en) * | 2008-05-09 | 2009-11-12 | Recopharma Ab | Compositions and methods for inhibiting shiga toxin and shiga-like toxin |
| JP2009288065A (ja) * | 2008-05-29 | 2009-12-10 | Keio Gijuku | Ｓｈｉｇａｔｏｘｉｎ２ｅ及びＳｈｉｇａｔｏｘｉｎ２ｅに対する抗体の検出方法 |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| WO2018015380A1 (en) * | 2016-07-18 | 2018-01-25 | Philippe Ulsemer | Natural microorganisms which are naturally capable of binding toxins and/or toxin receptors |
| CN106226536B (zh) * | 2016-08-01 | 2017-11-10 | 福建省产品质量检验研究院 | 一种沙门氏菌h抗原的位相变异试验方法 |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| CN112575041B (zh) * | 2019-09-30 | 2022-12-13 | 江南大学 | 一种混合碳源高效发酵生产phb的工程菌及其应用 |
| US20230277607A1 (en) | 2019-10-14 | 2023-09-07 | Acaryon Gmbh | Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof |
| EP4172181A1 (en) | 2020-06-26 | 2023-05-03 | University of Massachusetts | Anti-etec adhesin protein antibodies and methods of use |
| CN117004670B (zh) * | 2023-10-07 | 2023-12-15 | 中国科学院天津工业生物技术研究所 | 一种磺基转移酶及其应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6168418A (ja) | 1984-09-11 | 1986-04-08 | Kanto Ishi Pharma Co Ltd | 去痰薬 |
| US5089479A (en) | 1988-11-28 | 1992-02-18 | Krivan Howard C | Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
| JP2636042B2 (ja) | 1989-04-10 | 1997-07-30 | 株式会社三光開発科学研究所 | ４，４▲′′′▼―ジヒドロキシクォーターフェニル誘導体およびその製造方法 |
| US5032519A (en) | 1989-10-24 | 1991-07-16 | The Regents Of The Univ. Of California | Method for producing secretable glycosyltransferases and other Golgi processing enzymes |
| US5595900A (en) | 1990-02-14 | 1997-01-21 | The Regents Of The University Of Michigan | Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
| US5753631A (en) | 1990-06-15 | 1998-05-19 | Cytel Corporation | Intercellular adhesion mediators |
| US5576305A (en) | 1990-06-15 | 1996-11-19 | Cytel Corporation | Intercellular adhesion mediators |
| DE69130536T2 (de) * | 1990-08-02 | 1999-04-22 | Antex Biolog Inc | Adhäsionsrezeptoren für pathogene oder opportunistische mikroorganismen |
| US5260380A (en) | 1992-01-23 | 1993-11-09 | The University Of Akron | Self-reinforced composite and process for preparing same |
| JP3041840B2 (ja) | 1992-02-24 | 2000-05-15 | 東洋紡績株式会社 | 新規なグリセロールデヒドロゲナーゼ、その製法及びその用途 |
| MX9304638A (es) | 1992-07-31 | 1994-05-31 | Neose Pharm Inc | Composicion para tratar e inhibir las ulceras gastricas y duodenales. |
| US5401723A (en) | 1992-12-02 | 1995-03-28 | Colgate-Palmolive Company | Glycoconjugate inhibition of Streptococcus pyrogenes adhesion |
| US5811404A (en) | 1993-05-14 | 1998-09-22 | Cytel Corporation | Sialyl Lex analogues as inhibitors of cellular adhesion |
| JPH07258093A (ja) | 1994-03-23 | 1995-10-09 | Morinaga Milk Ind Co Ltd | 神経成長因子様剤 |
| US5665561A (en) | 1994-06-06 | 1997-09-09 | The Rockefeller University | Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications |
| US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US5627163A (en) | 1995-06-05 | 1997-05-06 | Synsorb Biotech, Inc. | Treatment of traveller's diarrhea |
| US5736533A (en) | 1995-06-07 | 1998-04-07 | Neose Technologies, Inc. | Bacterial inhibition with an oligosaccharide compound |
| CA2227013A1 (en) | 1995-07-14 | 1997-02-06 | Glycotech Corp. | Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| US6069137A (en) | 1996-03-11 | 2000-05-30 | Synsorb Biotech, Inc. | Treatment of traveller's diarrhea |
| JP2997419B2 (ja) | 1996-05-31 | 2000-01-11 | 雪印乳業株式会社 | 脳ガングリオシド含量減少抑制剤 |
| JPH107575A (ja) * | 1996-06-21 | 1998-01-13 | Synsorb Biotec Inc | 細菌性赤痢の処置 |
| JP4637976B2 (ja) | 1996-07-17 | 2011-02-23 | 雪印乳業株式会社 | 腸内代謝改善剤 |
| DE19640791A1 (de) | 1996-10-02 | 1998-04-16 | Syntesome Ges Fuer Medizinisch | Glycokonjugate als Inhibitoren der viralen Zelladhäsion |
| US20020019991A1 (en) | 1998-04-30 | 2002-02-14 | Abbott Laboratories | Compositions containing an alpha 1,2-fucose linkage and uses thereof |
| KR20020040664A (ko) * | 1999-05-18 | 2002-05-30 | 더블유. 브루스 위톤 | 복합 탄수화물의 제조 방법 |
| AUPQ275799A0 (en) * | 1999-09-10 | 1999-10-07 | Luminis Pty Limited | Recombinant bacterium expressing an oligosaccharide receptor mimic |
-
1999
- 1999-09-10 AU AUPQ2757A patent/AUPQ275799A0/en not_active Abandoned
-
2000
- 2000-09-09 OA OA1200200071A patent/OA12020A/en unknown
- 2000-09-09 BR BR0013915-7A patent/BR0013915A/pt not_active IP Right Cessation
- 2000-09-09 AP APAP/P/2002/002444A patent/AP2002002444A0/en unknown
- 2000-09-09 CA CA002384081A patent/CA2384081A1/en not_active Abandoned
- 2000-09-09 HU HU0202863A patent/HUP0202863A3/hu unknown
- 2000-09-09 JP JP2001523732A patent/JP2003514512A/ja not_active Withdrawn
- 2000-09-09 EP EP00958947A patent/EP1214396A4/en not_active Withdrawn
- 2000-09-09 MX MXPA02002536A patent/MXPA02002536A/es not_active Application Discontinuation
- 2000-09-09 WO PCT/IB2000/001349 patent/WO2001019960A1/en active IP Right Grant
- 2000-09-09 SK SK347-2002A patent/SK3472002A3/sk not_active Application Discontinuation
- 2000-09-09 NZ NZ517821A patent/NZ517821A/en unknown
- 2000-09-09 US US09/658,537 patent/US6833130B1/en not_active Expired - Lifetime
- 2000-09-09 PL PL00364796A patent/PL364796A1/xx not_active Application Discontinuation
-
2002
- 2002-03-08 ZA ZA200201958A patent/ZA200201958B/en unknown
- 2002-03-08 IN IN287DE2002 patent/IN2002DE00287A/en unknown
-
2004
- 2004-12-20 US US11/018,745 patent/US20050250196A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ517821A (en) | 2004-01-30 |
| EP1214396A4 (en) | 2008-01-02 |
| HUP0202863A3 (en) | 2006-07-28 |
| US6833130B1 (en) | 2004-12-21 |
| WO2001019960A1 (en) | 2001-03-22 |
| CA2384081A1 (en) | 2001-03-22 |
| JP2003514512A (ja) | 2003-04-22 |
| PL364796A1 (en) | 2004-12-13 |
| US20050250196A1 (en) | 2005-11-10 |
| EP1214396A1 (en) | 2002-06-19 |
| OA12020A (en) | 2006-04-19 |
| MXPA02002536A (es) | 2003-07-21 |
| AUPQ275799A0 (en) | 1999-10-07 |
| BR0013915A (pt) | 2002-11-19 |
| ZA200201958B (en) | 2003-05-28 |
| HUP0202863A2 (hu) | 2002-12-28 |
| SK3472002A3 (en) | 2002-10-08 |
| AP2002002444A0 (en) | 2002-03-31 |